UNSPSC 51385100: Nonsteroidal anti inflammatory pyrrolidines

Nonsteroidal anti inflammatory drugs made of tetrahydropyrroles.

UNSPSC 51385100 Nonsteroidal anti-inflammatory pyrrolidines, a Class code, does not align with the state and local opportunities recently tagged under it. The three recent solicitations span naloxone and drug deactivation systems procurement, direct-to-manufacturer pharmacy benefit program design, and generic multi-source pharmaceutical and OTC product supply — none of which fall within the code's nominal scope of nonsteroidal anti-inflammatory pyrrolidine compounds. The mismatch suggests either miscoding in the source data or a misclassification by issuing bodies. The code shows no recent relevant state and local activity grounded in its stated product category.

The recent opportunities do illustrate the broader pharmaceutical and health-product procurement landscape across state and local buyers. Seminole County, Florida issued an IFB (Solicitation IFB60459723LAS, due July 26, 2023) for naloxone and drug deactivation systems, requiring quarterly deliveries with vendor responsibility for shipping; the Texas Health and Human Services Commission posted an RFI (HHS0017013, April 3, 2026) exploring direct-to-manufacturer prescription models outside traditional pharmacy benefit manager arrangements; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by Minnesota's Office of State Procurement, issued an RFP (S1070000015802, due March 26, 2026) for generic pharmaceuticals and OTC products distributed through three authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson) to state and local facilities in Minnesota and Oregon. Absent correct UNSPSC coding, this code provides no reliable signal for business development targeting.